Measurement of carotid intima–media thickness to assess progression and regression of atherosclerosis
E De Groot, SI Van Leuven, R Duivenvoorden… - Nature clinical practice …, 2008 - nature.com
Imaging modalities have been developed to assess atherosclerosis in vivo in the arterial
wall because large clinical end-point studies are time-consuming and costly. Historically, in …
wall because large clinical end-point studies are time-consuming and costly. Historically, in …
Measurement of carotid intima-media thickness to assess progression and regression of atherosclerosis
E De Groot, SI Van Leuven… - Nature Reviews …, 2008 - search.proquest.com
Imaging modalities have been developed to assess atherosclerosis in vivo in the arterial
wall because large clinical end-point studies are time-consuming and costly. Historically, in …
wall because large clinical end-point studies are time-consuming and costly. Historically, in …
Measurement of carotid intima-media thickness to assess progression and regression of atherosclerosis.
E de Groot, SI van Leuven… - Nature Clinical …, 2008 - europepmc.org
Imaging modalities have been developed to assess atherosclerosis in vivo in the arterial
wall because large clinical end-point studies are time-consuming and costly. Historically, in …
wall because large clinical end-point studies are time-consuming and costly. Historically, in …
[引用][C] Measurement of carotid intima-media thickness to assess progression and regression of atherosclerosis
DE GROOT - Nat Clin Pract Cardiovasc Med, 2008 - cir.nii.ac.jp
[PDF][PDF] Measurement of carotid intima–media thickness to assess progression and regression of atherosclerosis
E de Groot, SI van Leuven… - Targeting the vessel …, 2005 - researchgate.net
Background: Imaging modalities have been developed to assess atherosclerosis in vivo in
the arterial wall because large clinical end-point studies are time-consuming and costly …
the arterial wall because large clinical end-point studies are time-consuming and costly …
Measurement of carotid intima-media thickness to assess progression and regression of atherosclerosis
E de Groot, SI van Leuven… - Nature clinical …, 2008 - pubmed.ncbi.nlm.nih.gov
Imaging modalities have been developed to assess atherosclerosis in vivo in the arterial
wall because large clinical end-point studies are time-consuming and costly. Historically, in …
wall because large clinical end-point studies are time-consuming and costly. Historically, in …
[PDF][PDF] Measurement of carotid intima–media thickness to assess progression and regression of atherosclerosis
E de Groot, SI van Leuven… - Targeting the vessel …, 2005 - academia.edu
Background: Imaging modalities have been developed to assess atherosclerosis in vivo in
the arterial wall because large clinical end-point studies are time-consuming and costly …
the arterial wall because large clinical end-point studies are time-consuming and costly …
[PDF][PDF] Measurement of carotid intima–media thickness to assess progression and regression of atherosclerosis
E de Groot, SI van Leuven, R Duivenvoorden… - Targeting the vessel wall … - dare.uva.nl
Background: Imaging modalities have been developed to assess atherosclerosis in vivo in
the arterial wall because large clinical end-point studies are time-consuming and costly …
the arterial wall because large clinical end-point studies are time-consuming and costly …
Measurement of carotid intima--media thickness to assess progression and regression of atherosclerosis
E de Groot, SI van Leuven, R Duivenvoorden… - Nature Clinical …, 2008 - go.gale.com
Imaging modalities have been developed to assess atherosclerosis in vivo in the arterial
wall because large clinical end-point studies are time-consuming and costly. Historically, in …
wall because large clinical end-point studies are time-consuming and costly. Historically, in …
Measurement of carotid intima-media thickness to assess progression and regression of atherosclerosis
E de Groot, SI van Leuven… - Nature clinical …, 2008 - researchinformation.amsterdamumc …
Imaging modalities have been developed to assess atherosclerosis in vivo in the arterial
wall because large clinical end-point studies are time-consuming and costly. Historically, in …
wall because large clinical end-point studies are time-consuming and costly. Historically, in …